Abstract
The indirect macrophage migration inhibition technique was used to study cellular hypersensitivity to autologous tumor extract in relation to the progress and prognosis of breast carcinoma. Cellular immune response, evidenced by production of a macrophage migration inhibitory factor (MIF), was noted preoperatively in 21 of 63 patients (33 per cent). This reactivity was used at the time of surgery to determine the grade of the primary tumor, lymph node involvement and the stage of the disease according to the TNM system. The five-year survival rate was 76 per cent for patients whose lymphocytes responded preoperatively and 54 per cent for patients whose lymphocytes did not respond, indicating that this assay may be valuable in detecting cellular immune response to breast carcinoma and in evaluating the immunological status of patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akiyoshi, T., Hata, A. and Tsuji, H.: In vitro cellular immune responses to autologous tumor extract detected by inhibition of macrophage migration,Gann 66: 167–174, 1974.
Akiyoshi, T., Kawaguchi, M. and Tsuji, H.: Effect of autologous plasma from patients with malignant tumor on macrophage migration inhibition with tumor extract,Gann submitted for publication.
Andersen, V., Bjerrum, O., Bendixen, G., Schiodt, T. and Dissing, I.: Effect of autologous mammary tumour extracts on human leucocyte migration in vitro,Int. J. Cancer 5: 357–363, 1970.
Black, M.M., Leis, H.P., Shore, B. and Zachrau, R.E.: Cellular hypersensitivity to breast cancer, assessment by a leucocyte migration procedure,Cancer 33: 952–958, 1974.
Cochran, A.J., Grant, R.M., Spilg, W.G., Mackie, R.M., Ross, C.E., Hoyle, D.E. and Russell, J.M.: Sensitization to tumour-associated antigens in human breast carcinoma,Int. J. Cancer 14: 19–25, 1974.
Hilberg, R.W., Balcerzak, S.P. and LoBuglio, A.F.: A migration inhibition-factor assay for tumour immunity in man,Cell Immunol. 7: 152–158, 1973.
Jones, B.M. and Turnbull, A.R.: In vitro cellular immunity in mammary carcinoma,Br. J. Cancer 29: 337–339, 1974.
Light, P.A., Preece, A.W. and Waldron, H.A.: Studies with macrophage migration inhibition (MMI) test in patients with malignant disease,Clin. Exp. Immunol. 22: 279–284, 1975.
McCoy, J.L., Jerome, L.F., Dean, J.H., Cannon, G.B., Alford, T.C., Doering, T. and Herberman, R.B.: Inhibition of leucocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma,J. Natl. Cancer Inst. 53: 11–17, 1974.
Merrell, J.P. and Shulman, L.E.: Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus,J. Chronic Dis. 1: 12–32, 1955.
Rocklin, R.D. and David, J.R.: In vitro methods in cell-mediated immunity, ed. B.R. Bloom and P.R. Glade, pp. 281–288, Academic Press, New York and London, 1971.
Wolberg, W.H.: Inhibition of migration of human autologous and allogeneic leucocytes by extracts of patients' cancers,Cancer Res. 31: 798–802, 1971.
Wolberg, W.H.: Inhibition of leucocyte migration by human tumors, effect on patient survival,Arch. Surg. 109: 211–214, 1974.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Akiyoshi, T., Nakamura, Y., Kawaguchi, M. et al. Cellular hypersensitivity to autologous tumor extract in patients with breast carcinoma. The Japanese Journal of Surgery 8, 236–241 (1978). https://doi.org/10.1007/BF02469449
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02469449